Prevalence of Trichomonas vaginalis infection in Hamadan city, Western Iran

Iranian Journal of Parasitology

Volumn 7, Issue 2, 2012, Pages 67-72

  Matini, M ^a   Rezaie, S ^a   Mohebali, M ^a   Maghsood, A H ^b   Rabiee, S ^c   Fallah, M ^b   Rezaeian, M ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Hamadan University of Medical Sciences   (Iran)

Author keywords

Culture; Iran; Trichomonas vaginalis infection; Wet mount

Indexed keywords

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; DESCRIPTIVE RESEARCH; FEMALE; HUMAN; IRAN; MAJOR CLINICAL STUDY; PATIENT REFERRAL; TRICHOMONAS VAGINALIS; TRICHOMONIASIS;

EID: 84862309247     PISSN: 17357020     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Ali V, Nozaki T. Current therapeutics, their problems, and sulfur-containing-amino-acid metabolism as a novel target against infections by amitochondriate protozoan parasites. Clin Microbiol Rev. 2007; 20(1): 164-187.
2. Schwebke JR, Burgess D. Trichomoniasis. Clin Microbiol Rev. 2004; 17(4): 794-803.
3. Burgess DE. Trichomonas infection. in:Cox FEG, Gillespie SH, Despommier DD, editors. Topley & Wilsonés Microbiology & Microbial Infection, Parasitology. London: Hodder Arnold; 2005.p261.
4. World Health Organization. Global prevalence and incidence of selected curable sexually transmitted infections. WHO, Geneva, Switzerland.2001.
5. Jhon DT, Petri WA. Markell and Vogés Medical Parasitology. 9th ed. St.Louis: Sanders; 2006.
6. st ed. Tehran University of Medical Sciences.2007.
7. Wright JM, Dunn LA, Kazimierczuk Z, Burgess AG, Krauer KG, Upcroft P, Upcroft JA. Susceptibility in vitro of clinically met-ronidazole- resistant Trichomonas vaginalis to nitazoxanide, toyocamycin, and 2- fluoro-2'-deoxyadenosine. Parasitol Res. 2010; 107(4): 847-853.
8. Xiao JC, Xie LF, Fang SL, Gao MY, Zhu Y, Song LY, Zhong HM, Lun ZR. Symbiosis of Mycoplasma hominis in Trichomonas vaginalis may link metronidazole resistance in vitro. Parasitol Res.2006;100(1):123-130.
9. Meri T, Jokiranta TS, Suhonen L, Meri S. Resistance of Trichomonas vaginalis to metronidazole: report of the first three cases from Finland and optimization of in vitro susceptibility testing under various oxygen concentrations. J Clin Microbiol. 2000; 38(2):763-767.
10. Crowell AL, Sanders-Lewis KA, Secor WE. In vitro metronidazole and tinidazole activities against metronidazole-resistant strains of Trichomonas vaginalis. Antimicrob Agents Chemother. 2003;47(4):1407-1409.
11. Petrin D, Delgaty K, Bhatt R, Garber G. Clinical and microbiological aspects of Trichomonas vaginalis. Clin Microbiol Rev.1998;11(2):300-317.
12. Cudmore SL, Delgaty KL, Hayward-McClel-land SF, Petrin DP, Garber GE. Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis. Clin Microbiol Rev.2004;17(4):783-793.
13. Bashirybod H. Human Parasitic Infection. 1st ed. Tehran University of Medical Science, Tehran, Iran; 1988.
14. World Health Organization. Basic laboratory methods in medical parasitology. 1th ed. World Health Organization: Geneva; 1991.
15. Khan NA. Emerging Protozoan Pathogenes. 1st ed. Taylor & Francis group. 2008.
16. Conrad M, Zubacova Z, Dunn LA, Upcroft J, Sullivan SA, Tachezy J, Carlton JM. Microsatellite polymorphism in the sexually transmitted human pathogen Trichomonas vaginalis indicates a genetically diverse parasite. pathogen Trichomonas vaginalis indicates a genetically diverse parasite. Mol Biochem Parasitol. 2011;175:30-38.
17. Kassem HH, Majoud OA. Trichomoniasis among women with vaginal discharge in Benghazi city, Libya. J Egypt Soc Parasitol.2006; 36(3):1007-1016.
18. Mahafzah AM, Al-Ramahi MQ, Asa'd AM, El-Khateeb MS. Prevalence of sexually transmitted infections among sexually active Jordanian females. Sex Transm Dis.2008; 35(6):607-610.
19. Selvitopu A, Ozcelik S, Degerli S. The incidence of Trichomonas vaginalis in vaginal specimens from gynecologic patients. Turkiye Parazitol Derg. 2006; 30(3):175-177.
20. Madani TA. Sexually transmitted infections in Saudi Arabia. BMC Infect Dis. 2006; 6:3.
21. Mazloumi Gavgani A-S, Namazi A, Ghazan-chaei A, Alizadeh S, Sehhati F, Ros-tamzadeh S, Dolatkhah A. Prevalence and risk factors of trichomoniasis among women in Tabriz. Iranian Journal of Clinical Infectious Diseases.2008;3(2):67-71.
22. Rezaeian M, Vatanshenassan M, Rezaie S, Mohebal M, Niromand N, Niyyati M, Farnia S, Babaei Z. Prevalence of Trichomonas vaginalis Using Parasitological Methods in Tehran. Iranian J Parasitol. 2009;4(4):43-47.
23. Bakhtiari A, Hajian-Tilaki K, Pasha H. Genital infection by Trichomonas Vaginalis in women referring to Babol health centers: prevalence and risk factors. IRCMJ. 2008;10(1):16-21.
24. Fattahi Bafghi A, Aflatoonian A, Barzegar K, Ghafourzadeh M, Nabipour S. Frequency distribution of trichomoniasis in pregnant women referred to health centers of Ardakan, Meibod and Yazd, Iran. Jundishapur Journal of Microbiology.2009; 2(4):132-139.
25. Rabieea, S, Fallahb M, Zahabic F. Frequency of Trichomoniasis in Patients Admitted To Outpatient Clinics in Hamadan (2007) and relationship between Clinical Diagnosis and Laboratory Findings. JRHS.2010;10(1):31-35.
26. Habibi-Pour R, Amir-Khani A, Matin-Nia N. Study of Trichomonas vaginalis infection in women attending Tamin-Ejtemaee hospital in Hamadan infection in women attending Tamin-Ejtemaee hospital in Hamadan. Sciences. 2006; 8(4):9-15.
27. Shobeiri F, Nazari M. A prospective study of genital infections in Hamadan,Iran. Southeast Asian J Trop Med Public Health. 2006; 37(3)174-177.
28. Vatanshenassan M, Rezaie S, Mohebali M, Niromand N, Kazemi B, Babaei Z, Rezaeian M. Trichomonas vaginalis: investigation of a novel diagnostic method in urine samples using cysteine proteinase 4 gene and PCR technique. Exp Parasitol.2010;126(2):187-190.